A progression risk assessment model for pulmonary ground-glass nodules based on traditional Chinese medicine clinical symptoms combined with imaging.

Saved in:
Bibliographic Details
Title: A progression risk assessment model for pulmonary ground-glass nodules based on traditional Chinese medicine clinical symptoms combined with imaging.
Authors: Maolan A; Department of Oncology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China; School of Graduates, Beijing University of Chinese Medicine, Beijing 100029, China., Yu LH; Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 10070, China; School of Mathematics and Statistics, Hunan University of Science and Technology, Changsha 411201, Hunan Province, China., Li Y; Department of Oncology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China; School of Graduates, Beijing University of Chinese Medicine, Beijing 100029, China., Yan ZS; Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 10070, China; Department of Mathematics and Physics, North China Electric Power University, Baoding 071003, Hebei Province, China., Xiang XH; Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 10070, China., Wang LF; Department of Oncology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China., Guo QJ; Department of Oncology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China., Hu JQ; Department of Oncology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China., Zhang GH; Department of Oncology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China; School of Graduates, Beijing University of Chinese Medicine, Beijing 100029, China., Ren XL; Department of Oncology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China., Li J; Department of Oncology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China; School of Graduates, Beijing University of Chinese Medicine, Beijing 100029, China., Sun TH; Department of Oncology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China., Yang W; Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences, Beijing 10070, China. Electronic address: yangyxq@ruc.edu.cn., Liu R; Department of Oncology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China. Electronic address: liurui3378@gamyy.cn., Hua BJ; Department of Oncology, Guang'anmen Hospital, China Academy of Chinese Medical Sciences, Beijing 100053, China. Electronic address: huabaojin@sohu.com.
Source: Journal of integrative medicine [J Integr Med] 2026 May; Vol. 24 (3), pp. 376-386. Date of Electronic Publication: 2026 Jan 16.
Publication Type: Journal Article
Journal Info: Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101603118 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2095-4964 (Print) NLM ISO Abbreviation: J Integr Med Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:2095-4964
DOI:10.1016/j.joim.2026.01.002